Bishai WR - Search Results

1

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat.

Zetola N, Francis JS, Nuermberger EL, Bishai WR. Zetola N, et al. Among authors: bishai wr. Lancet Infect Dis. 2005 May;5(5):275-86. doi: 10.1016/S1473-3099(05)70112-2. Lancet Infect Dis. 2005. PMID: 15854883 Review.

2

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

Yoshimatsu T, Nuermberger E, Tyagi S, Chaisson R, Bishai W, Grosset J. Yoshimatsu T, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):1875-9. doi: 10.1128/AAC.46.6.1875-1879.2002. Antimicrob Agents Chemother. 2002. PMID: 12019103 Free PMC article.

3

Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections.

Bishai W. Bishai W. Clin Ther. 2002 Jun;24(6):838-50; discussion 837. doi: 10.1016/s0149-2918(02)80002-9. Clin Ther. 2002. PMID: 12117077 Review.

4

Fluoroquinolones, tuberculosis, and resistance.

Ginsburg AS, Grosset JH, Bishai WR. Ginsburg AS, et al. Among authors: bishai wr. Lancet Infect Dis. 2003 Jul;3(7):432-42. doi: 10.1016/s1473-3099(03)00671-6. Lancet Infect Dis. 2003. PMID: 12837348 Review.

5

Significance of macrolide resistance in Streptococcus pneumoniae.

Nuermberger EL, Bishai WR. Nuermberger EL, et al. Among authors: bishai wr. J Antimicrob Chemother. 2003 Sep;52(3):524-5; author reply 525. doi: 10.1093/jac/dkg349. Epub 2003 Jul 29. J Antimicrob Chemother. 2003. PMID: 12888594 No abstract available.

6

Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.

Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Nuermberger EL, et al. Among authors: bishai wr. Am J Respir Crit Care Med. 2004 Feb 1;169(3):421-6. doi: 10.1164/rccm.200310-1380OC. Epub 2003 Oct 24. Am J Respir Crit Care Med. 2004. PMID: 14578218

7

Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.

Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, Diener-West M, Merz WG, Bishai WR, Sterling TR. Ginsburg AS, et al. Among authors: bishai wr. Clin Infect Dis. 2003 Dec 1;37(11):1448-52. doi: 10.1086/379328. Epub 2003 Nov 4. Clin Infect Dis. 2003. PMID: 14614666

8

The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.

Nuermberger E, Bishai WR. Nuermberger E, et al. Among authors: bishai wr. Clin Infect Dis. 2004 Jan 1;38(1):99-103. doi: 10.1086/380126. Epub 2003 Dec 8. Clin Infect Dis. 2004. PMID: 14679455 Review.

9

Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

Nuermberger EL, Yoshimatsu T, Tyagi S, Bishai WR, Grosset JH. Nuermberger EL, et al. Among authors: bishai wr. Infect Immun. 2004 Feb;72(2):1065-71. doi: 10.1128/IAI.72.2.1065-1071.2004. Infect Immun. 2004. PMID: 14742554 Free PMC article.

10

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

Nettles RE, Mazo D, Alwood K, Gachuhi R, Maltas G, Wendel K, Cronin W, Hooper N, Bishai W, Sterling TR. Nettles RE, et al. Clin Infect Dis. 2004 Mar 1;38(5):731-6. doi: 10.1086/381675. Epub 2004 Feb 17. Clin Infect Dis. 2004. PMID: 14986259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

344 results

Search Page